HOX gene dysregulation in head and neck squamous cell carcinoma: mechanisms, clinical relevance, and future perspectives - Takeaways - MDSpire

HOX gene dysregulation in head and neck squamous cell carcinoma: mechanisms, clinical relevance, and future perspectives

  • By

  • Norma Carolina Hernandez-Bautista

  • Claudia Altamirano-Torres

  • Jose Manuel Vazquez-Guillen

  • Reyes S. Tamez-Guerra

  • Cristina Rodríguez-Padilla

  • Diana Resendez-Perez

  • June 15, 2026

  • 0 min

Share

  • 1

    Dysregulation of HOX genes is a significant feature in head and neck squamous cell carcinoma (HNSCC), impacting tumor initiation and progression.

  • 2

    HOX genes function as transcription factors that regulate essential cellular processes relevant to tumor development, including proliferation and differentiation.

  • 3

    In HNSCC, specific HOX genes are overexpressed or downregulated depending on the tumor subtype, indicating their context-dependent roles.

  • 4

    The clinical exploitation of HOX genes as biomarkers or therapeutic targets in HNSCC remains limited, highlighting the need for further research.

  • 5

    Future research should focus on understanding the regulatory mechanisms of HOX gene dysregulation and their implications for targeted therapies in HNSCC.

Original Source(s)

HOX gene dysregulation in head and neck squamous cell carcinoma: mechanisms, clinical relevance, and future perspectives

  • by Norma Carolina Hernandez-Bautista, Claudia Altamirano-Torres, Jose Manuel Vazquez-Guillen, Reyes S. Tamez-Guerra, Cristina Rodríguez-Padilla, Diana Resendez-Perez

  • June 15, 2026

Related Content

Clinicopathologic features and integrated outcome analysis of pediatric and young adult salivary secretory carcinoma

Case Report: Decade-delayed thyroid metastasis with cervical lymph node involvement from clear cell renal cell carcinoma: diagnostic pitfalls of cytologic-radiologic discordance

Nucleo-mitochondrial asymmetry profiles the proliferative engine and spatial niche reconstruction in clear cell renal cell carcinoma